Enzo Biochem Total Revenue

Enzo Biochem (ENZ) currently reports a total revenue of $27M as of April 2025. That compares with $4.7M in the prior-year period — up 482.0% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Enzo Biochem's total revenue history and peer comparisons.

Enzo Biochem's total revenue increased from $4.7M to $27M — a 482.0% year-over-year increase (period ending April 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enzo Biochem's total revenue of $27M is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Enzo Biochem reported $27M in total revenue as of April 2025. That compares with $4.7M in the prior-year period — up 482.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $27M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Enzo Biochem, and consider following ENZ for alerts when major investors trade the stock.